Skip to content

Study · Animal study (in vivo) · mouse · 2009

5 results

New use of thymosin alpha1

KEFU ZHOU, SHIYUAN WANG, WEI HAN, HANZHOU WU, SHENGFA LIU

Journal not recorded7 Oct 2008

PepBankPUB-98364828
Source linkAsk about this study

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study5

5 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In mice, thymosin alpha‑1 slowed down weight increase.

    In plain wordsIn mice, thymosin alpha‑1 slowed weight gain. The patent abstract gives no numbers.

    Outcome
    DecreaseBody weight increase
    Study

    mousen: not reported in source

    Outcome group
    Body weight · Metabolic and weight
    Studied dose
    Dose not stated · oralAs given in this study (mouse).

    Source sentences

    Summary
    slow down the weight increase of a mouse
    1 context sentence
    Summary · context
    the effect of obviously slowing down weight increase can be realized
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In mice, thymosin alpha‑1 lowered the normal fasting blood sugar.

    In plain wordsIn mice, thymosin alpha‑1 lowered fasting blood sugar. The patent abstract gives no numbers.

    Outcome
    DecreaseNormal fasting blood sugar
    Study

    mousen: not reported in source

    Outcome group
    Glycemic control · Metabolic and weight
    Studied dose
    Dose not stated

    Source sentences

    Summary
    lower the normal fasting blood sugar of the mouse
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In mice, thymosin alpha‑1 obviously enhanced sugar tolerance.

    In plain wordsIn mice, thymosin alpha‑1 improved the handling of sugar. The patent abstract gives no numbers.

    Outcome
    IncreaseGlucose tolerance
    Study

    mousen: not reported in source

    Outcome group
    Glycemic control · Metabolic and weight
    Studied dose
    Dose not stated

    Source sentences

    Summary
    obviously enhance the sugar tolerance of the mouse
  4. 04AnimalAnimal study (in vivo)Efficacy outcome

    In mice, thymosin alpha‑1 prevented STZ from inducing diabetes.

    In plain wordsIn mice, thymosin alpha‑1 prevented diabetes caused by STZ. The patent abstract gives no numbers.

    Outcome
    DecreaseSTZ-induced diabetes occurrence
    Study

    mousen: not reported in source

    Outcome group
    Glycemic control · Metabolic and weight
    Studied dose
    Dose not stated

    Source sentences

    Summary
    prevent STZ from inducing the occurrence of diabetes of the mouse
  5. 05AnimalAnimal study (in vivo)Efficacy outcome

    In mice, thymosin alpha‑1 is stated to protect the structure of islet cells.

    In plain wordsIn mice, thymosin alpha‑1 is said to protect pancreatic islet cells. The patent abstract gives no data.

    Outcome
    Not applicableIslet cell structure
    Study

    mousen: not reported in source

    Outcome group
    Islet protection · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    protecting the structure of islet cells

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.